Olivia Cavlan
Partner at LifeArc Ventures
About
Joined LifeArc Ventures in 2025, having co-founded Alchemab Therapeutics where she was Chief Corporate Development and Strategy Officer. Previously an Investment Principal at SV Health Investors and a Partner at McKinsey & Company in its healthcare practices.
Colleagues at LifeArc Ventures
Chris Baker
Investment Principal at LifeArc Ventures
Clare Terlouw
Managing Partner / Head of LifeArc Ventures at LifeArc Ventures
Deborah Harland
Chair, LifeArc Ventures Investment Committee at LifeArc Ventures
Diana Röttger
Investment Principal at LifeArc Ventures
Etienne Cousin
Investment Associate at LifeArc Ventures
Ian Gilham
Chair of Board of Trustees at LifeArc Ventures
Jonathan Nash
Investment Principal at LifeArc Ventures
Matthew Lulham-Robinson
Investment Associate at LifeArc Ventures